Specialty Account Manager, Auvelity (Springfield, MA)

The role

The Specialty Account Manager will execute commercial activities and establish customer relationships to promote AUVELITY. This field-based role involves managing product performance at a territory level and acting as a disease category expert.

What you will do

• Develop a comprehensive and effective territory business plan
• Promote within approved labeling in a fair and ethical manner
• Develop strong customer relationships
• Serve as a resource regarding payer policies and processes
• Maximize use of marketing resources to grow customer confidence
• Communicate territory activity to management
• Provide feedback to sales, commercial leadership, and internal departments
• Complete all training classes and administrative duties
• Manage efforts within assigned promotional budget
• Attend medical congresses and society meetings as needed

Required qualifications

• Bachelor’s degree from an accredited college or university
• Minimum of 5 years of field customer experience and/or account management
• Minimum of 3 years Healthcare Professional experience with relevant CNS experience will also meet the qualifications
• 5 years of consistent top performance in the pharmaceutical, biotech or medical sales space
• Must live in the territory's geography
• Experience strategizing within cross-functional teams
• Proven ability to successfully manage multiple tasks concurrently
• Strong interpersonal, presentation, and communication skills
• Frequent driving, including extended periods of time behind the wheel
• Prolonged sitting and standing
• Ability to lift and carry up to 30 lbs regularly
• Overhead reaching required to close and secure liftgates or similar equipment

Nice to have

• Psychiatry/CNS experience
• Launch experience
• Patient support services experience
• Strong digital marketing aptitude

Benefits

• Annual bonus
• Significant equity
• Generous benefits package

About the company

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Their neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness, and migraine.